Search Press releases Keywords From To 15 Nov 2016 The Lancet Publishes First Head-to-Head Study of Cimzia® (certolizumab pegol) and Humira® (adalimumab) in Bio-Naïve Rheumatoid Arthritis Patients Read More 14 Nov 2016 Results from Phase 3 Bridge study showed romosozumab significantly increased bone mineral density in men with Osteoporosis Read More 11 Nov 2016 UCB’s anti-epileptic drug VIMPAT® (lacosamide) receives positive opinion by EU CHMP as monotherapy for patients with partial-onset seizures Read More 11 Nov 2016 UCB showcases advancements in its late stage immunology portfolio through innovative research at 2016 ACR/ARHP Annual Meeting Read More 7 Nov 2016 Transparency notifications Read More 25 Oct 2016 UCB continues its growth path Read More Pagination First page Previous page Previous … Page 86 Page 87 Page 88 Page 89 Current page 90 Page 91 Page 92 Page 93 Page 94 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
